PharmAthene, Inc. (AMEX: PIP) announced today that it has entered into a purchase agreement to sell $3.9 million of its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE